###begin article-title 0
Negative regulation of fibroblast growth factor 10 (FGF-10) by polyoma enhancer activator 3 (PEA3)
###end article-title 0
###begin p 1
This document may be redistributed and reused, subject to .
###end p 1
###begin title 2
Abstract
###end title 2
###begin p 3
###xml 322 327 322 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 401 407 401 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 731 737 731 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 803 809 803 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 879 885 879 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 1196 1202 1196 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 394 400 <span type="species:ncbi:10090">murine</span>
###xml 902 908 <span type="species:ncbi:10090">murine</span>
###xml 963 968 <span type="species:ncbi:9606">human</span>
FGF-10 plays an important role in development and disease, acting as the key ligand for FGFR2B to regulate cell proliferation, migration and differentiation. Aberrant FGF signalling is implicated in tumourigenesis, with several cancer studies reporting FGF-10 or FGFR2B upregulation or identifying activating mutations in Fgfr2. We used 5' RACE to identify a novel transcription start site for murine Fgf-10. Conventional in silico analysis predicted multiple binding sites for the transcription factor PEA3 upstream of this site. Binding was confirmed by chromatin immunopreciptation, and functional significance was studied by both RNAi knockdown and transient over-expression of PEA3. Knockdown of PEA3 message led to increased Fgf-10 expression, whereas overexpression of PEA3 resulted in decreased Fgf-10 expression. Thus, we have identified PEA3 as a negative regulator of Fgf-10 expression in a murine cell line and confirmed that activity also is seen in human breast cancer cell lines (MCF-7 and MDA-MB-231). Furthermore, over-expression of PEA3 in these cells resulted in impaired cell migration, which was rescued by treatment with FGF-10. Thus, PEA3 can regulate the transcription of Fgf-10 and such modulation can control breast cancer cell behaviour.
###end p 3
###begin title 4
Keywords
###end title 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 240 261 240 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib42" ref-type="bibr">Ornitz and Itoh, 2001</xref>
###xml 390 407 390 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib4" ref-type="bibr">Beer et al., 1997</xref>
###xml 481 497 481 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib39" ref-type="bibr">Min et al., 1998</xref>
###xml 499 518 499 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib47" ref-type="bibr">Sekine et al., 1999</xref>
###xml 671 689 671 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib54" ref-type="bibr">Zhang et al., 2006</xref>
###xml 792 810 792 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10" ref-type="bibr">Celli et al., 1998</xref>
###xml 812 837 812 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15" ref-type="bibr">De Moerlooze et al., 2000</xref>
###xml 839 855 839 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib39" ref-type="bibr">Min et al., 1998</xref>
###xml 857 876 857 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib47" ref-type="bibr">Sekine et al., 1999</xref>
###xml 711 715 <span type="species:ncbi:10090">mice</span>
Fibroblast growth factors (FGFs) comprise a family of 22 members that play important roles during embryogenesis and adulthood, regulating a wide range of cellular behaviours including proliferation, migration, survival and differentiation (Ornitz and Itoh, 2001). Genetic studies have shown that FGF-10, a secreted glycoprotein that acts as a paracrine signalling molecule in many tissues (Beer et al., 1997), is crucial for epithelial-mesenchymal interactions during development (Min et al., 1998; Sekine et al., 1999). FGF-10 signals through two transmembrane tyrosine kinase receptors - FGFR1B and FGFR2B, to which it binds with low and high affinities, respectively (Zhang et al., 2006). Genetic studies in mice have shown FGFR2B to be the key receptor for transducing FGF-10 signalling (Celli et al., 1998; De Moerlooze et al., 2000; Min et al., 1998; Sekine et al., 1999).
###end p 6
###begin p 7
###xml 116 122 116 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 243 263 243 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib45" ref-type="bibr">Rohmann et al., 2006</xref>
###xml 265 283 265 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib48" ref-type="bibr">Shams et al., 2007</xref>
###xml 357 378 357 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib25" ref-type="bibr">Ibrahimi et al., 2004</xref>
###xml 380 399 380 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib51" ref-type="bibr">Wilkie et al., 2002</xref>
###xml 528 549 528 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib36" ref-type="bibr">Matsuike et al., 2001</xref>
###xml 551 574 551 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib37" ref-type="bibr">Memarzadeh et al., 2007</xref>
###xml 576 595 576 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib41" ref-type="bibr">Nomura et al., 2008</xref>
###xml 597 619 597 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib50" ref-type="bibr">Theodorou et al., 2004</xref>
###xml 722 745 722 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19" ref-type="bibr">Grose and Dickson, 2005</xref>
###xml 747 758 747 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib29" ref-type="bibr">Katoh, 2008</xref>
###xml 876 895 876 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib32" ref-type="bibr">Kurban et al., 2004</xref>
###xml 897 918 897 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib36" ref-type="bibr">Matsuike et al., 2001</xref>
###xml 920 943 920 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib37" ref-type="bibr">Memarzadeh et al., 2007</xref>
###xml 945 963 945 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib38" ref-type="bibr">Meyer et al., 2008</xref>
###xml 965 984 965 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib41" ref-type="bibr">Nomura et al., 2008</xref>
###xml 1029 1034 1029 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr2</italic>
###xml 1111 1130 1111 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1" ref-type="bibr">Adnane et al., 1991</xref>
###xml 1132 1151 1132 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr">Davies et al., 2005</xref>
###xml 1153 1170 1153 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib27" ref-type="bibr">Jang et al., 2001</xref>
###xml 1172 1192 1172 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib43" ref-type="bibr">Pollock et al., 2007</xref>
###xml 1384 1403 1384 1403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr">Easton et al., 2007</xref>
###xml 1405 1424 1405 1424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib24" ref-type="bibr">Hunter et al., 2007</xref>
###xml 1426 1444 1426 1444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib38" ref-type="bibr">Meyer et al., 2008</xref>
###xml 1629 1646 1629 1646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17" ref-type="bibr">Feng et al., 1997</xref>
###xml 1648 1666 1648 1666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib20" ref-type="bibr">Grose et al., 2007</xref>
###xml 1668 1686 1668 1686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib44" ref-type="bibr">Ricol et al., 1999</xref>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
###xml 235 241 <span type="species:ncbi:9606">humans</span>
###xml 1172 1179 <span type="species:ncbi:8060">Pollock</span>
Aberrant FGF signalling has been linked not only with developmental abnormalities but also with cancer. Hypomorphic Fgf-10 mutations have been shown to cause lacrimo-auriculo-dento-digital (LADD) syndrome-like defects in both mice and humans (Rohmann et al., 2006; Shams et al., 2007), and FGF-10 has been implicated in the development of craniosynostosis (Ibrahimi et al., 2004; Wilkie et al., 2002). Increased expression of FGF-10 has been described in several tumours, including those of the colorectum, prostate and breast (Matsuike et al., 2001; Memarzadeh et al., 2007; Nomura et al., 2008; Theodorou et al., 2004). Likewise, FGFR2B has been implicated in cancer susceptibility and progression in a variety of ways (Grose and Dickson, 2005; Katoh, 2008). Elevated expression of FGFR2B has been described in breast, colorectal, cervical, pancreatic and prostate cancers (Kurban et al., 2004; Matsuike et al., 2001; Memarzadeh et al., 2007; Meyer et al., 2008; Nomura et al., 2008). Activating mutations or amplifications of Fgfr2 also have been identified in breast, lung, stomach and endometrial cancers (Adnane et al., 1991; Davies et al., 2005; Jang et al., 2001; Pollock et al., 2007). Furthermore, genome-wide single-nucleotide polymorphism (SNP) analyses have identified SNPs in FGFR2 that result in increased susceptibility to breast cancer by elevating FGFR2 expression (Easton et al., 2007; Hunter et al., 2007; Meyer et al., 2008). However, although FGFR2 signalling clearly plays an oncogenic role in some cancers, in several tissues, including bladder, skin and prostate, it also can act as a tumour suppressor (Feng et al., 1997; Grose et al., 2007; Ricol et al., 1999).
###end p 7
###begin p 8
###xml 102 117 102 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib49" ref-type="bibr">Sharrocks, 2001</xref>
###xml 365 382 365 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib52" ref-type="bibr">Xing et al., 2000</xref>
###xml 384 399 384 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib53" ref-type="bibr">Yu et al., 2006</xref>
###xml 556 573 556 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5" ref-type="bibr">Benz et al., 1997</xref>
###xml 575 596 575 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr">Davidson et al., 2003</xref>
###xml 598 618 598 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib22" ref-type="bibr">Hiroumi et al., 2001</xref>
###xml 620 636 620 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib34" ref-type="bibr">Liu et al., 2004</xref>
###xml 341 346 <span type="species:ncbi:10090">mouse</span>
Polyoma enhancer activator 3 (PEA3), a member of the PEA3 family of ETS-family transcription factors (Sharrocks, 2001), also has been reported to play both oncogenic and tumour-suppressive roles in cancer. PEA3 expression has been shown to exert anti-proliferative effects on breast and ovarian cancer cells, and also to improve survival in mouse models of cancer (Xing et al., 2000; Yu et al., 2006). However, there are also many studies implicating PEA3 as a driving factor in several neoplasms, including breast, colorectal and lung and ovarian cancer (Benz et al., 1997; Davidson et al., 2003; Hiroumi et al., 2001; Liu et al., 2004).
###end p 8
###begin p 9
###xml 106 136 106 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11" ref-type="bibr">Chotteau-Lelievre et al., 1997</xref>
###xml 139 143 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pea3</italic>
###xml 350 366 350 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib33" ref-type="bibr">Liu et al., 2003</xref>
###xml 395 416 395 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib31" ref-type="bibr">Kobberup et al., 2007</xref>
###xml 462 466 462 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pea3</italic>
###xml 589 595 589 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
PEA3 family members are expressed at many sites of epithelial-mesenchymal interaction during development (Chotteau-Lelievre et al., 1997). Pea3 has been identified as a target of FGF-10/FGFR2B signalling in the developing lung, where its expression is induced in distal lung bud epithelial cells in response to a mesenchymally-derived FGF-10 signal (Liu et al., 2003), and also in the pancreas (Kobberup et al., 2007). Thus, although FGF-10 is known to regulate Pea3 expression, our study is the first to describe the converse interaction; that is that PEA3 can regulate the expression of Fgf-10.
###end p 9
###begin p 10
###xml 91 97 91 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 99 120 99 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib30" ref-type="bibr">Katoh and Katoh, 2005</xref>
###xml 363 369 363 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 84 90 <span type="species:ncbi:10090">murine</span>
Despite a previous in silico study having predicted the transcription start site of murine Fgf-10 (Katoh and Katoh, 2005), no experimental evidence exists to support this location. Since FGF-10 signalling provides a powerful regulatory signal, both in development and cancer, the aim of our present study was to identify a definitive transcription start site for Fgf-10 in order to investigate possible regulatory mechanisms that may control its expression.
###end p 10
###begin title 11
Materials and methods
###end title 11
###begin title 12
Cell culture
###end title 12
###begin p 13
###xml 346 362 346 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib28" ref-type="bibr">Jat et al., 1991</xref>
###xml 662 665 654 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 1012 1013 992 993 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 150 156 <span type="species:ncbi:9913">bovine</span>
###xml 269 274 <span type="species:ncbi:10090">mouse</span>
###xml 334 339 <span type="species:ncbi:10090">mouse</span>
MDA-MB-231 and MCF-7 cells were grown in Dulbecco's modified Eagle's medium (DMEM) without phenol red (Sigma, Poole, UK) supplemented with 10% foetal bovine serum (FBS; Biosera, Ringmer, UK) and 4 mM L-glutamine (CR-UK LRI Cell Services, Potters Bar, UK). Immortalised mouse endothelial cells, generated from an H-2KbtsA58 transgenic mouse line (Jat et al., 1991), were a kind gift from Dr. Gabi D'Amico Lago and Dr. Kairbaan Hodivala-Dilke. Endothelial cells were seeded into T75 Nunc tissue culture flasks (VWR, Lutterworth, UK) pre-coated for 1 h at 37 degreesC with 0.1% gelatine (Sigma), 10 mug/ml fibronectin (Sigma) and 30 mug/ml collagen (type I; PureCol(R)) (Inamed Biomaterials, Nutacon, The Netherlands). Cells were grown in low-glucose DMEM:Hams F-12 (1:1; CR-UK Cell Services), supplemented with 10% FBS, 4 mM L-glutamine, 20 U/ml IFN-gamma (Peprotech, London, UK), 0.05 mg/ml endothelial mitogen (Biogenesis, Poole, UK) and 0.01 mg/ml heparin (Sigma). All cells were incubated at 37 degreesC, 8% CO2 and 100% relative humidity.
###end p 13
###begin title 14
RNA ligase-mediated rapid amplification of cDNA ends (RLM-RACE)
###end title 14
###begin p 15
###xml 60 66 60 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 106 109 106 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 371 377 368 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 437 444 434 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">Table 1</xref>
###xml 516 517 513 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 630 636 627 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 795 806 792 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib46" ref-type="bibr">Schug, 2003</xref>
###xml 53 59 <span type="species:ncbi:10090">murine</span>
###xml 253 258 <span type="species:ncbi:10090">mouse</span>
###xml 623 629 <span type="species:ncbi:10090">murine</span>
RLM-RACE was performed for the identification of the murine Fgf-10 transcription start site. A FirstChoice(R) RACE-ready cDNA kit was used according to the manufacturer's instructions (Ambion, Warrington, UK). Briefly, total RNA was isolated from E18.5 mouse lung using TriReagent (Sigma) and 10 mug was used for 5' RLM-RACE, to facilitate the cloning of the full-length Fgf-10 5' cDNA sequence. 5' RLM-RACE adapter sequence is given in Table 1. Taq-amplified 5' RLM-RACE PCR products were cloned into pBluescript SK- vector (Stratagene, Cheshire, UK), and four clones were sequenced fully. The putative promoter region of murine Fgf-10 (the 500 bp directly upstream of the newly identified transription start site) was analysed in silico using the 'Transcription Element Search System' (TESS) (Schug, 2003).
###end p 15
###begin title 16
Nested PCR for 5' RLM-RACE
###end title 16
###begin p 17
###xml 82 85 82 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 319 326 315 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">Table 1</xref>
Nested PCR was performed according to the manufacturer's instructions (FirstChoice(R) RACE-ready cDNA kit, Ambion). Briefly, 1 mul of the reverse transcriptase reaction was used for the outer 5' RLM-RACE PCR, and 1 mul from the first PCR was used for the subsequent inner 5' RLM-RACE PCR. Primer sequences are given in Table 1. Outer and inner PCRs were performed as follows: 3 min at 94 degreesC; 35 cycles (94 degreesC for 30 s, 60 degreesC for 30 s, 72 degreesC for 30 s); 72 degreesC for 7 min. Results were analysed by electrophoresis on a 2% agarose/TBE gel.
###end p 17
###begin title 18
Chromatin immunoprecipitation (ChIP) analysis
###end title 18
###begin p 19
###xml 193 199 193 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 418 419 412 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 2141 2147 2096 2102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 2152 2157 2107 2112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 232 237 <span type="species:ncbi:10090">mouse</span>
ChIP was performed, according to the manufacturer's instructions (ChIP kit; Upstate Biotechnology, Dundee, UK), to identify a possible interaction between the transcription factor PEA3 and the Fgf-10 promoter. Briefly, immortalised mouse endothelial cells were used as starting material, with chromatin cross-linked by fixation in 1% formaldehyde for 10 min at 37 degreesC prior to lysing the cells. Approximately 1x106 cells were lysed in 200 mul SDS lysis buffer (Upstate Biotechnology), and the was DNA sheared by sonication (4x10 s sonication; 6 mum amplitude with a 30-s break between each round; Soniprep 150 MSE, Sanyo, Japan) to an average length of approximately 500 bp. The range of DNA fragment size was confirmed by reversing the crosslinks with 8 mul 5 M NaCl in 200 mul cell lysate at 65 degreesC for 4 h, recovering the DNA by phenol/chlorophorm extraction and electrophoresing the sample on a 1% agarose/TBE gel). The sonicated cell lysate was diluted 10-fold in ChIP dilution buffer (Upstate), and 1% of the diluted DNA was kept as the input control for subsequent PCR analysis. Histones were pre-cleaned with salmon sperm DNA/protein A agarose 50% slurry for 1 h at 4 degreesC with agitation. Pre-cleaned chromatin was immunoprecipitated with 2 mug anti-PEA3 antibody (Santa Cruz, Heidelberg, Germany), anti-RNA polymerase II antibody (positive control; Upstate Biotechnology) or IgG1 control (BD Pharmingen, Oxford, UK) per sample overnight at 4 degreesC with constant rotation. The antibody/histone complex was collected by adding salmon sperm DNA/protein A agarose slurry (30% of the total sample volume) for 1 h at 4 degreesC with constant rotation. The samples were washed and eluted according to the manufacturer's instructions. Both the immunoprecipitated and the control input samples (each in 500 mul volume) were then subjected to cross-link reversal. To each sample was added; 10 mul 0.5 M EDTA, 20 mul 1 M Tris-HCl, pH 6.5, and 2 mul of 10 mg/ml proteinase K, and samples were incubated for 1 h at 45 degreesC. DNA was recovered by phenol/chloroform extraction and ethanol precipitation. PCR was performed with Fgf-10 and GAPDH (positive control) primers (as used above).
###end p 19
###begin title 20
RNA interference
###end title 20
###begin p 21
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pea3</italic>
###xml 108 113 <span type="species:ncbi:10090">mouse</span>
Cells (40-50% confluent in 6-well plates) were transfected for 4 h with 100 nM siRNA (Genome smart pool for mouse Pea3 ETV4, NM_008815; D-001206-13-05; Dharmacon, Cramlington, UK) using Oligofectamine (Invitrogen, Paisley, UK). mRNA, protein level and functional activity were assayed 24-72 h post-transfection, and compared with mock- and/or control siRNA-treated cells (SiControl non-targeting siRNA pool; D-001210-02-20, Dharmacon). Transfection efficiency was assessed independently using a positive control siRNA lamin A/C (D-001050-01-05, Dharmacon) which was compared with the SiControl non-targeting siRNA.
###end p 21
###begin title 22
Cloning PEA3-encoding cDNA and transient transfection
###end title 22
###begin p 23
###xml 136 143 136 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">Table 1</xref>
###xml 320 340 320 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr">Boukamp et al., 1988</xref>
###xml 249 254 <span type="species:ncbi:9606">human</span>
Forward and reverse PCR primers containing engineered BamHI and XbaI recognition sites, respectively (bold in primer sequences given in Table 1), were used to amplify the full-length coding sequence of PEA3 from total RNA isolated from immortalised human keratinocytes (HaCaT cell line; kind gift of Prof Petra Boukamp (Boukamp et al., 1988)). The primers were used at an annealing temperature of 60 degreesC. The hPEA3 PCR product was cloned into the BamHI and XbaI sites of the pcDNA4/TO mammalian expression vector (Invitrogen).
###end p 23
###begin p 24
MDA-MB-231 and MCF-7 cells were transfected with 1 mug DNA using 3 mul Lipofectamine 2000 (Invitrogen) for 4 h. Transfection efficiency of both cell lines was >85%, as determined by immunofluorescence imaging following transfection with a control pcDNA4/TO-GFP vector expressing green fluorescent protein (data not shown).
###end p 24
###begin title 25
RT-PCR and real-time RT-PCR
###end title 25
###begin p 26
###xml 164 167 164 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 243 246 241 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 420 424 416 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT</italic>
###xml 472 477 468 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
Extraction of total RNA was performed using an RNeasy kit (Qiagen, Crawley, UK). All samples were treated with DNase prior to synthesis of cDNA using Superscript II(R) Reverse Transcriptase (Invitrogen). RT-PCR was performed using Megamix Blue(R) PCR mastermix (Cambio, Cambridge, UK). Real-time RT-PCR was performed using a QuantiTech SYBR Green RT-PCR kit (Qiagen) with hypoxanthine-guanine phosphoribosyltransferase (HPRT) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as housekeeping genes for normalisation. For real-time RT-PCR the threshold amplification cycles were determined using a 7900HT Fast Real-Time PCR machine (Applied Biosystems, Warrington, UK).
###end p 26
###begin p 27
###xml 39 46 39 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">Table 1</xref>
The primer pair sequences are given in Table 1. All primers were used at an annealing temperature of 60 degreesC.
###end p 27
###begin title 28
Western blotting
###end title 28
###begin p 29
###xml 415 418 411 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 424 427 418 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 572 577 <span type="species:ncbi:10090">mouse</span>
###xml 582 587 <span type="species:ncbi:9606">human</span>
###xml 654 659 <span type="species:ncbi:10090">mouse</span>
###xml 664 669 <span type="species:ncbi:9606">human</span>
###xml 728 733 <span type="species:ncbi:10090">mouse</span>
###xml 735 740 <span type="species:ncbi:9606">human</span>
###xml 742 745 <span type="species:ncbi:10116">rat</span>
###xml 823 828 <span type="species:ncbi:10090">mouse</span>
###xml 833 838 <span type="species:ncbi:9606">human</span>
Cell lysates were prepared using RIPA buffer (Upstate Biotechnology) containing 1 mM NaF, 1 mug/ml aprotinin, 1 mug/ml leupeptin, 1 mug/ml pepstatin, 1 mM phenylmethylsulphonyl fluoride (PMSF) (all Sigma) and the protein yield was determined using a Bradford dye binding assay (Bio-Rad, Hercules, USA). Equivalent amounts of protein from different lysate samples (60 mug/well) were resolved by pre-cast 4-12% NuPAGE(R) Novex(R) Bis-Tris mini Gels (Invitrogen) gel electrophoresis. Four primary antibodies were used: anti-alpha-tubulin antibody (1:2000; Sigma; reactivity: mouse and human); anti-FGF-10 antibody (1:1000; Abcam, Cambridge, UK; reactivity: mouse and human); anti-PEA3 (1:500; Santa Cruz Biotechnology; reactivity: mouse, human, rat); anti-lamin A/C antibody (0.5 mug/ml; Santa Cruz Biotechnology; reactivity: mouse and human). Blots were developed with ECL (GE Healthcare, Amersham, UK). Densitometric analysis was performed using Image-Pro Plus software (Media Cybernetics, Bethesda, USA). Signal density was normalised to anti-alpha-tubulin antibody as a loading control/reference, for at least three separate treatments.
###end p 29
###begin title 30
Migration assay
###end title 30
###begin p 31
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 51 54 50 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 597 600 594 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 774 777 769 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 949 955 <span type="species:ncbi:3635">cotton</span>
Cells (1x105) were plated onto 8 mum-pore Transwell(R) migration filters in 24-well plates (Corning, New York, USA). PEA3- and/or empty vector-transfected cells were used 36 h post-transfection. Cells were incubated either in DMEM supplemented with 4 mM L-glutamine and 1-10% FBS gradient or in DMEM supplemented with 0.1% BSA (Sigma) and with 4 mM L-glutamine without FBS overnight (12 h). Where mentioned, recombinant FGF-10 (100 ng/ml; Peprotech, London, UK) together with heparin (300 ng/ml; Sigma) was added to the serum-free medium. When an FBS gradient was used, the bottom of the Transwell(R) membrane was pre-coated with 0.01% poly- L-lysine solution (Sigma) for 1 h at room temperature prior to plating the cells. In the absence of FBS, the bottom of the Transwell(R) was coated with 10 mug/ml fibronectin (Sigma) for 1 h at 37 degreesC prior to plating the cells. Cells from the upper chamber, which had not migrated, were removed with a cotton bud. Cells that had migrated to the lower surface were trypsinised and the cell number was determined using an automatic CASY cell counter (Scharfe system, Leipzig, Germany).
###end p 31
###begin title 32
Proliferation assay
###end title 32
###begin p 33
###xml 48 49 48 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
PEA3 and/or empty vector-transfected cells (5x104) were plated in a 24-well plate in DMEM supplemented with 4 mM L-glutamine and 10% FBS. Cells were trypsinised and counted after 12 h using an automatic CASY cell counter.
###end p 33
###begin title 34
Data analysis
###end title 34
###begin p 35
###xml 144 145 142 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 363 376 361 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;Ct</sup>
###xml 385 411 375 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib35" ref-type="bibr">Livak and Schmittgen, 2001</xref>
All quantitative data are presented as means+/-standard errors, unless stated otherwise. Statistical significance was determined with Student's t-test or Mann-Whitney Rank Sum test as appropriate. When multiple conditions were compared, one way analysis of variance (ANOVA) followed by Newman-Keuls test was performed. Real-time PCR data were analysed using the 2-DeltaDeltaCt method (Livak and Schmittgen, 2001). Results were considered significant at P<0.05 (*). Unless otherwise stated, all experiments were performed in triplicate as a minimum.
###end p 35
###begin title 36
Results
###end title 36
###begin title 37
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
Identification of a novel Fgf-10 transcription start site
###end title 37
###begin p 38
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 71 92 71 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib30" ref-type="bibr">Katoh and Katoh, 2005</xref>
###xml 260 266 260 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 439 445 439 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 564 570 564 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 621 627 621 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 804 810 804 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 1041 1047 1041 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 1482 1486 1482 1486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT</italic>
###xml 1604 1610 1604 1610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 191 196 <span type="species:ncbi:10090">mouse</span>
###xml 984 989 <span type="species:ncbi:10090">mouse</span>
Previous studies have predicted the Fgf-10 transcriptional start site (Katoh and Katoh, 2005), but unequivocal experimental evidence for this activity was lacking. Using total RNA from E18.5 mouse lung tissue, we performed 5' RLM-RACE in order to identify the Fgf-10 transcription start site. Subsequently, nested PCR was performed with specific forward primers for the 5' RLM-RACE adaptor and reverse primers from a known sequence of the Fgf-10 gene (data not shown). Taq-amplified 5' RLM-RACE PCR products were cloned and four independent clones were sequenced (Fig. 1B). Here we report that we have identified a novel Fgf-10 transcription start site, located 251 bp upstream of that predicted in silico, 653 bp upstream of the published Entrez site and 1001 bp upstream of the translation start site (Fig. 1A). Our results were confirmed by RT-PCR using a forward primer from over the newly identified transcription start which amplified a band both with cDNA generated from E18.5 mouse lung and with positive control genomic DNA (gDNA) (Fig. 1B). In contrast, RT-PCR using a forward primer recognising the 20 base pairs directly upstream of the predicted transcription start site amplified a band only with the positive control (gDNA) and not with the cDNA. Control primers, specific to an intronic sequence, confirmed the absence of genomic DNA contamination in the cDNA sample, while control primers, specific for a cDNA sequence known to be expressed (the housekeeping gene, HPRT), gave a strongly positive band. Thus, these data support our 5' RLM-RACE results, suggesting a novel start site for Fgf-10 transcription 1001 bp upstream of the translation start site.
###end p 38
###begin title 39
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
PEA3 binds to the Fgf-10 promotor region
###end title 39
###begin p 40
###xml 50 56 50 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 331 337 331 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 499 505 499 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 325 330 <span type="species:ncbi:9606">human</span>
###xml 479 484 <span type="species:ncbi:9606">human</span>
We then analysed the immediate upstream region of Fgf-10 using an on-line Transcription Element Search System (TESS). Analysis revealed a region of approximately 120 bp in the newly defined promoter region containing 12 copies of the consensus binding sequence for PEA3 (AGGAA). This string of sites was not conserved in the human Fgf-10 promoter, however, there were several PEA3 recognition sites within the region. Interestingly, 8 PEA3-binding sites also were present in the human (NC_000005.8) Fgf-10 promoter region in conserved positions.
###end p 40
###begin p 41
###xml 40 46 40 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 259 265 259 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 337 343 337 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 469 474 469 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 593 599 593 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 698 704 698 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 735 741 735 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 982 987 982 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 1022 1028 1022 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 1115 1121 1115 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 113 118 <span type="species:ncbi:10090">mouse</span>
To confirm interaction of PEA3 with the Fgf-10 promotor region, we performed ChIP experiments using immortalised mouse lung endothelial cells. RT-PCR analysis with appropriate controls confirmed that these cells expressed both FGF-10- and PEA3-encoding mRNA (Fig. 2A). Importantly, these cells expressed readily detectable PEA3 protein (Fig. 2B). An antibody to RNA polymerase II was used as a positive control for ChIP, with specific DNA binding confirmed by PCR with GAPDH primers. As expected, only the sample immunoprecipitated using anti-RNA polymerase II antibody yielded a PCR product (Fig. 2C, top panel). When chromatin was immunoprecipitated with antibodies to PEA3 or RNA polymerase II, Fgf-10 sequence was detected by PCR (Fig. 2C, bottom panel). Importantly, the negative controls, where the same ChIP protocol was followed either with IgG or no antibody, gave no PCR products, suggesting that our ChIP results were a result of specific binding of RNA polymerase II to GAPDH and PEA3 and RNA polymerase II to Fgf-10, respectively. Thus, our ChIP results confirmed the binding of PEA3 to the endogenous Fgf-10 promoter region.
###end p 41
###begin title 42
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
PEA3 negatively regulates Fgf-10 expression
###end title 42
###begin p 43
###xml 52 58 52 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 454 460 454 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 584 590 584 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 911 917 911 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 1072 1078 1072 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 223 228 <span type="species:ncbi:10090">mouse</span>
To determine the role for PEA3 in the regulation of Fgf-10 expression, we used both RNAi-mediated knockdown and recombinant overexpression approaches, with subsequent real-time RT-PCR analysis. Transfection of immortalised mouse lung endothelial cells with a pool of RNAi oligos targeted specifically to PEA3 reduced the level of PEA3-encoding mRNA expression by 65% and 57%, after 24 h and 48 h, respectively, when compared to a scrambled RNAi control (Fig. 3A). By 48 h post-RNAi treatment, Western blotting of whole cell extracts showed PEA3 protein levels to be decreased by 34% (Fig. 3B). However, by 72 h post-treatment the PEA3 protein levels in RNAi-treated cells had returned to control levels (data not shown). Interestingly, although FGF-10 mRNA levels had not changed by 24 h post-RNAi treatment, after 48 h the level of FGF-10 mRNA in RNAi-treated cells was 260% higher than that of control cells (Fig. 3C). Thus, RNAi-mediated knockdown of PEA3 resulted in upregulation of FGF-10 mRNA levels, implying that PEA3 may play a negative role in the regulation of Fgf-10 expression.
###end p 43
###begin p 44
###xml 61 67 61 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 194 216 194 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib50" ref-type="bibr">Theodorou et al., 2004</xref>
###xml 419 458 419 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec1" ref-type="sec">Supplementary Fig. 1 and data not shown</xref>
###xml 637 655 637 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2" ref-type="bibr">Baert et al., 1997</xref>
Having shown that reducing PEA3 levels led to an increase in Fgf-10 expression, we determined whether the converse also was true. Since FGF-10 upregulation has been implicated in breast cancer (Theodorou et al., 2004), we used MDA-MB-231 and MCF-7 breast cancer cell lines as models in which to overexpress recombinant PEA3. Both cell lines expressed FGF-10 mRNA and protein as well as PEA3 mRNA, but not PEA3 protein (Supplementary Fig. 1 and data not shown). This finding was consistent with a previous study that reported, in a number of breast cancer cell lines including MDA-MB-231 and MCF-7 cells, PEA3 protein was not detectable (Baert et al., 1997).
###end p 44
###begin p 45
###xml 477 483 477 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 609 615 609 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 752 758 752 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 850 856 850 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 920 926 920 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 1155 1161 1155 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 1077 1082 <span type="species:ncbi:10090">mouse</span>
Firstly, we cloned the full-length human PEA3-encoding cDNA sequence into a mammalian expression vector, pcDNA4/TO, and confirmed orientation and fidelity by sequencing the whole insert (data not shown). Within 48 h of transient transfection with our PEA3 expression construct, real-time RT-PCR revealed that levels of PEA3 mRNA expression in MDA-MB-231 cells increased by over 3000-fold compared to the negligible levels seen in cells transfected with empty pcDNA4/TO vector (Fig. 4A). Similarly, PEA3 protein was detected readily in PEA3-transfected MDA-MB-231 cells, but not in empty vector control cells (Fig. 4B). Crucially, at the same 48 h timepoint, PEA3-transfected cells showed a 73% reduction in FGF-10 mRNA expression relative to controls (Fig. 4A). Similar results were obtained at the protein level, with FGF-10 protein reduced by 70% (Fig. 4B). Thus, over-expression of PEA3 in MDA-MB-231 cells decreased Fgf-10 expression. Similar results were obtained with MCF-7 cells (data not shown). These results are consistent with the RNAi-mediated knockdown of PEA3 in mouse lung endothelial cells, suggesting that PEA3 is a negative regulator of Fgf-10 expression.
###end p 45
###begin p 46
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT</italic>
###xml 90 95 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
All real-time PCR results were performed using two different housekeeping genes (HPRT and GAPDH) as controls. The data presented were normalised to HPRT mRNA levels, however the results were the same when GAPDH was used for normalisation (Data not shown).
###end p 46
###begin title 47
Over-expression of PEA3 in breast cancer cells decreases cell migration
###end title 47
###begin p 48
###xml 125 128 125 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 147 153 145 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 330 333 328 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 586 592 582 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 704 724 700 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec1" ref-type="sec">Supplementary Fig. 2</xref>
###xml 1030 1036 1026 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 1102 1123 1098 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib42" ref-type="bibr">Ornitz and Itoh, 2001</xref>
###xml 1436 1442 1432 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
In order to investigate whether PEA3 over-expression had any functional effect on breast cancer cells, we performed Transwell(R) migration assays (Fig. 5A). Cells were allowed to migrate in the absence of FBS, since FBS contains a number of potential growth factors that might influence cell migration. The bottom of the Transwell(R) membrane was coated with fibronectin, allowing cells migrating through the membrane to adhere to the lower surface. Interestingly, over-expression of PEA3 decreased cell migration to 62% of control levels in MDA-MB-231 cells and to 65% in MCF-7 cells (Fig. 5A). Identical results were obtained when cells were allowed to migrate in the presence of a 1-10% FBS gradient (Supplementary Fig. 2). To determine whether the inhibitory effect of PEA3 was dependent on FGF-10, we added recombinant FGF-10 (100 ng/ml) to the medium of cells transfected with a PEA3 expression construct and empty vector controls, resulting in a rescue in the migratory capacity of PEA3-expressing cells to control levels (Fig. 5A). Given that one major outcome of FGF-10 signalling is mitosis (Ornitz and Itoh, 2001), we confirmed that differences in cell proliferation did not influence our migration data. Cells in all experimental groups showed no differences in proliferation over the same timeframe that was used for our migration experiment, as expected for an assay conducted in serum-free conditions over a 12-h period (Fig. 5B). Thus, we have shown a significant inhibitory effect of PEA3 expression on cell migration and demonstrated that this reduction in migration is rescued by treatment with exogenous FGF-10.
###end p 48
###begin p 49
###xml 74 80 74 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 238 244 238 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
Taken together, our results identify a novel transcription start site for Fgf-10 and show that the transcription factor PEA3 binds upstream of this site. We go on to provide functional evidence for a role of PEA3 in negatively regulating Fgf-10 expression, supported by RNAi knockdown, over-expression and recombinant rescue studies. From the present study, we show that PEA3 can exert an important inhibitory effect on cell migration, acting at least in part via FGF-10.
###end p 49
###begin title 50
Discussion
###end title 50
###begin p 51
###xml 219 237 219 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8" ref-type="bibr">Braun et al., 2004</xref>
###xml 239 264 239 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15" ref-type="bibr">De Moerlooze et al., 2000</xref>
###xml 266 282 266 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib39" ref-type="bibr">Min et al., 1998</xref>
###xml 284 303 284 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib47" ref-type="bibr">Sekine et al., 1999</xref>
###xml 467 484 467 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17" ref-type="bibr">Feng et al., 1997</xref>
###xml 486 509 486 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19" ref-type="bibr">Grose and Dickson, 2005</xref>
###xml 511 529 511 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib20" ref-type="bibr">Grose et al., 2007</xref>
###xml 531 549 531 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib44" ref-type="bibr">Ricol et al., 1999</xref>
###xml 551 569 551 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib55" ref-type="bibr">Zhang et al., 2001</xref>
Despite apparently modest levels of expression, the FGF-10-FGFR2B signalling axis plays a critical role in controlling cell proliferation, apoptosis, cytoprotection and migration during embryogenesis and tissue repair (Braun et al., 2004; De Moerlooze et al., 2000; Min et al., 1998; Sekine et al., 1999). Therefore, although there are several studies reporting a tumour-suppressive effect of FGFR2 in a variety of cancer types, including bladder, prostate and skin (Feng et al., 1997; Grose and Dickson, 2005; Grose et al., 2007; Ricol et al., 1999; Zhang et al., 2001), it is easy to see how the pathway might be hijacked by cancer cells to provide them with a significant growth advantage.
###end p 51
###begin p 52
###xml 273 293 273 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib26" ref-type="bibr">Iwasaki et al., 2004</xref>
###xml 511 528 511 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib52" ref-type="bibr">Xing et al., 2000</xref>
###xml 645 663 645 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib40" ref-type="bibr">Myers et al., 2006</xref>
###xml 770 790 770 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib3" ref-type="bibr">Barrett et al., 2002</xref>
###xml 792 811 792 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib6" ref-type="bibr">Bieche et al., 2004</xref>
###xml 813 837 813 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr">Cowden Dahl et al., 2007</xref>
Similarly to FGFR2, the literature concerning PEA3 and cancer is somewhat equivocal. Our study has shown that PEA3 overexpression in MDA-MB-231 cells decreased cell migration, and it previously has been shown that PEA3 can decrease invasion in a cervical cancer cell line (Iwasaki et al., 2004). However, the role of PEA3 in metastatic cell behaviour and cancer prognosis is contradictory. In breast cancer, PEA3 has been reported to act as a tumour suppressor gene by downregulating HER-2/neu over-expression (Xing et al., 2000). However, it also has been reported that PEA3 can play a positive role in HER2-mediated breast cancer progression (Myers et al., 2006) and that it can function as an oncogene through up-regulation of MMPs both in breast and ovarian cancer (Barrett et al., 2002; Bieche et al., 2004; Cowden Dahl et al., 2007).
###end p 52
###begin p 53
###xml 187 193 187 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 233 239 233 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 660 685 660 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib9" ref-type="bibr">Butler and Kadonaga, 2002</xref>
###xml 687 716 687 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib21" ref-type="bibr">Gross and Oelgeschlager, 2006</xref>
###xml 797 804 797 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10,</italic>
###xml 867 873 867 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 1056 1062 1056 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 1202 1208 1202 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 1504 1510 1504 1510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
Before examining regulatory elements in a gene promoter region, it clearly is essential to know the location of the true transcriptional start site. Therefore, we have identified a novel Fgf-10 transcription start site and show that Fgf-10 transcription is regulated by PEA3. The genomic sequence upstream of this transcription start site does not contain a canonical TATA box, however it is within a well-defined GC-rich region. The requirement for a TATA box is thought to have been overestimated since a large number of mammalian genes lack such a sequence, yet can direct accurate transcription using initiator and other downstream core promotor elements (Butler and Kadonaga, 2002; Gross and Oelgeschlager, 2006). Our study does not prove that this is the only transcriptional start site for Fgf-10, but it does show a novel regulatory mechanism for controlling Fgf-10 expression. We provide clear evidence that, at least in the two breast cancer cell lines that we have used in this current study, over-expression of PEA3 has a negative influence on Fgf-10 expression, consistent with our PEA3 knockdown data from endothelial cells, suggesting that PEA3 appears to act as a negative regulator of Fgf-10 expression. Given the complexity of the literature regarding tumourigenic or tumour-suppressive effects of PEA3 and FGFR2B, it is possible that these effects may be cell-context dependent but the results from all the three cell lines that we have used all concur with PEA3 negatively regulating Fgf-10 expression.
###end p 53
###begin p 54
Both assay conditions that we employed to analyse cell migration, either in response to an FBS gradient or in serum-free conditions, showed that over-expression of PEA3 resulted in significant reduction in cell migration. The two assays have different merits. The FBS gradient allowed cells to migrate in a relatively undefined, but perhaps more physiologically representative, environment of various mitogenic and motogenic stimuli. Conversely, the more defined serum-free conditions were useful in determining the effect of PEA3 expression in a relatively unstimulated cell population. Regardless of their individual benefits, both assay formats gave essentially identical results. The migration assays were conducted over a relatively short timeframe of 12 h, where cell proliferation did not differ between empty vector- and PEA3-transfected cells, with or without exogenous FGF-10 treatment.
###end p 54
###begin p 55
###xml 133 139 133 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 230 236 230 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 331 355 331 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18" ref-type="bibr">Fuchs and Allgayer, 2003</xref>
###xml 357 374 357 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23" ref-type="bibr">Howe et al., 2001</xref>
In the present study, we speculate that the inhibitory role of PEA3 on breast cancer cell migration could be due to the reduction of Fgf-10 expression by negative regulation through PEA3. Of course, expression of genes other than Fgf-10 will be affected by increased expression of PEA3, potentially including MMPs, uPAR and Cox-2 (Fuchs and Allgayer, 2003; Howe et al., 2001), several of which might affect cell migration. However, the rescue of the defective migration of PEA3-expressing cells by treatment with exogenous FGF-10 suggests that PEA3 acts via FGF-10. It is beyond the scope of this study to identify all the potential molecular targets that might mediate the inhibitory effect of PEA3 on the migration of MDA-MB-231 and MCF-7 cells.
###end p 55
###begin p 56
###xml 139 143 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pea3</italic>
###xml 188 209 188 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib31" ref-type="bibr">Kobberup et al., 2007</xref>
###xml 211 227 211 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib33" ref-type="bibr">Liu et al., 2003</xref>
###xml 379 385 379 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 181 186 <span type="species:ncbi:10090">mouse</span>
The novel relationship between PEA3 and FGF-10 is interesting in light of previous findings that FGF-10 signalling can positively regulate Pea3 expression during development in the mouse (Kobberup et al., 2007; Liu et al., 2003), and suggests a possible mechanism for preventing establishment of an autocrine FGF-10 positive feedback loop in cells that receive an FGF-10 signal (Fig. 6). In breast cancer cells, the lack of PEA3 could result in exactly such an autocrine situation. Thus our data suggest that the negative effect of PEA3 on cell migration in breast cancer cells warrants further investigation.
###end p 56
###begin title 57
Supplementary data
###end title 57
###begin p 58
Supplementary data associated with this article can be found in the online version at .
###end p 58
###begin title 59
Supplementary data
###end title 59
###begin p 60
###xml 0 23 0 23 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="61">Supplementary Materials</p>
###xml 23 23 23 23 <media xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="mmc1.jpg" mimetype="text" mime-subtype="plain"/>
###xml 0 23 0 23 <supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="local-data" id="N0x1c7ea20N0x2c6a180"><p textid="61">Supplementary Materials</p><media xlink:href="mmc1.jpg" mimetype="text" mime-subtype="plain"/></supplementary-material>
###xml 23 46 23 46 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="62">Supplementary Materials</p>
###xml 46 46 46 46 <media xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="mmc2.jpg" mimetype="text" mime-subtype="plain"/>
###xml 23 46 23 46 <supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="local-data" id="N0x1c7ea20N0x2c6a2a0"><p textid="62">Supplementary Materials</p><media xlink:href="mmc2.jpg" mimetype="text" mime-subtype="plain"/></supplementary-material>
Supplementary MaterialsSupplementary Materials
###end p 60
###begin p 61
Supplementary Materials
###end p 61
###begin p 62
Supplementary Materials
###end p 62
###begin title 63
Acknowledgments
###end title 63
###begin p 64
We thank Professors Sabine Werner, Helen Hurst and Ian Hart for critical comments on the manuscript. This study was funded by The Wellcome Trust.
###end p 64
###begin title 65
References
###end title 65
###begin article-title 66
###xml 85 90 <span type="species:ncbi:9606">human</span>
BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers
###end article-title 66
###begin article-title 67
###xml 69 74 <span type="species:ncbi:9606">human</span>
Expression of the PEA3 group of ETS-related transcription factors in human breast-cancer cells
###end article-title 67
###begin article-title 68
###xml 86 91 <span type="species:ncbi:9606">human</span>
Expression of Ets-related transcription factors and matrix metalloproteinase genes in human breast cancer cells
###end article-title 68
###begin article-title 69
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse fibroblast growth factor 10: cDNA cloning, protein characterization, and regulation of mRNA expression
###end article-title 69
###begin article-title 70
###xml 82 87 <span type="species:ncbi:9606">human</span>
HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer
###end article-title 70
###begin article-title 71
Expression of PEA3/E1AF/ETV4, an Ets-related transcription factor, in breast tumors: positive links to MMP2, NRG1 and CGB expression
###end article-title 71
###begin article-title 72
###xml 64 69 <span type="species:ncbi:9606">human</span>
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line
###end article-title 72
###begin article-title 73
Fibroblast growth factors in epithelial repair and cytoprotection
###end article-title 73
###begin article-title 74
The RNA polymerase II core promoter: a key component in the regulation of gene expression
###end article-title 74
###begin article-title 75
Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning
###end article-title 75
###begin article-title 76
###xml 81 87 <span type="species:ncbi:10090">murine</span>
Differential expression patterns of the PEA3 group transcription factors through murine embryonic development
###end article-title 76
###begin article-title 77
PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells
###end article-title 77
###begin article-title 78
PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma
###end article-title 78
###begin article-title 79
###xml 55 60 <span type="species:ncbi:9606">human</span>
Somatic mutations of the protein kinase gene family in human lung cancer
###end article-title 79
###begin article-title 80
###xml 130 135 <span type="species:ncbi:10090">mouse</span>
An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis
###end article-title 80
###begin article-title 81
Genome-wide association study identifies novel breast cancer susceptibility loci
###end article-title 81
###begin article-title 82
Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells
###end article-title 82
###begin article-title 83
Transcriptional regulation of the urokinase receptor (u-PAR) - a central molecule of invasion and metastasis
###end article-title 83
###begin article-title 84
Fibroblast growth factor signaling in tumorigenesis
###end article-title 84
###begin article-title 85
The role of fibroblast growth factor receptor 2b in skin homeostasis and cancer development
###end article-title 85
###begin article-title 86
Core promoter-selective RNA polymerase II transcription
###end article-title 86
###begin article-title 87
###xml 64 69 <span type="species:ncbi:9606">human</span>
Expression of E1AF/PEA3, an Ets-related transcription factor in human non-small-cell lung cancers: its relevance in cell motility and invasion
###end article-title 87
###begin article-title 88
PEA3 is up-regulated in response to Wnt1 and activates the expression of cyclooxygenase-2
###end article-title 88
###begin article-title 89
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
###end article-title 89
###begin article-title 90
Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities
###end article-title 90
###begin article-title 91
E1AF/PEA3 reduces the invasiveness of SiHa cervical cancer cells by activating serine proteinase inhibitor squamous cell carcinoma antigen
###end article-title 91
###begin article-title 92
###xml 111 116 <span type="species:ncbi:9606">human</span>
Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers
###end article-title 92
###begin article-title 93
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse
###end article-title 93
###begin article-title 94
Cancer genomics and genetics of FGFR2
###end article-title 94
###begin article-title 95
Comparative genomics on FGF7, FGF10, FGF22 orthologs, and identification of fgf25
###end article-title 95
###begin article-title 96
ETS-family genes in pancreatic development
###end article-title 96
###begin article-title 97
###xml 71 76 <span type="species:ncbi:9606">human</span>
Expression of keratinocyte growth factor receptor (KGFR/FGFR2 IIIb) in human uterine cervical cancer
###end article-title 97
###begin article-title 98
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
Role for ETS domain transcription factors Pea3/Erm in mouse lung development
###end article-title 98
###begin article-title 99
Polyoma enhancer activator 3, an ets transcription factor, mediates the induction of cyclooxygenase-2 by nitric oxide in colorectal cancer cells
###end article-title 99
###begin article-title 100
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ddCt method
###end article-title 100
###begin article-title 101
###xml 51 56 <span type="species:ncbi:9606">human</span>
Expression of fibroblast growth factor (FGF)-10 in human colorectal adenocarcinoma cells
###end article-title 101
###begin article-title 102
Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor
###end article-title 102
###begin article-title 103
Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer
###end article-title 103
###begin article-title 104
###xml 101 111 <span type="species:ncbi:7227">Drosophila</span>
Fgf-10 is required for both limb and lung development and exhibits striking functional similarity to Drosophila branchless
###end article-title 104
###begin article-title 105
A positive role for PEA3 in HER2-mediated breast tumour progression
###end article-title 105
###begin article-title 106
FGF10/FGFR2 signal induces cell migration and invasion in pancreatic cancer
###end article-title 106
###begin article-title 107
Fibroblast growth factors
###end article-title 107
###begin article-title 108
Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes
###end article-title 108
###begin article-title 109
###xml 77 82 <span type="species:ncbi:9606">human</span>
Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer
###end article-title 109
###begin article-title 110
Mutations in different components of FGF signaling in LADD syndrome
###end article-title 110
###begin article-title 111
Using TESS to predict transcription factor binding sites in DNA sequences
###end article-title 111
###begin article-title 112
Fgf10 is essential for limb and lung formation
###end article-title 112
###begin article-title 113
Lacrimo-auriculo-dento-digital syndrome is caused by reduced activity of the fibroblast growth factor 10 (FGF10)-FGF receptor 2 signaling pathway
###end article-title 113
###begin article-title 114
The ETS-domain transcription factor family
###end article-title 114
###begin article-title 115
###xml 34 38 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
###xml 120 125 <span type="species:ncbi:9606">human</span>
Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas
###end article-title 115
###begin article-title 116
###xml 27 32 <span type="species:ncbi:9606">human</span>
FGFs, their receptors, and human limb malformations: clinical and molecular correlations
###end article-title 116
###begin article-title 117
The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis
###end article-title 117
###begin article-title 118
Antitumor activity of an Ets protein, PEA3, in breast cancer cell lines MDA-MB-361DYT2 and BT474M1
###end article-title 118
###begin article-title 119
Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family
###end article-title 119
###begin article-title 120
###xml 60 65 <span type="species:ncbi:9606">human</span>
Growth inhibition by keratinocyte growth factor receptor of human salivary adenocarcinoma cells through induction of differentiation and apoptosis
###end article-title 120
###begin p 121
###xml 27 33 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 43 49 43 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 260 266 260 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 848 854 848 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 1050 1054 1050 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hPRT</italic>
###xml 1159 1164 1159 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-3</italic>
###xml 199 204 <span type="species:ncbi:10090">mouse</span>
###xml 489 494 <span type="species:ncbi:10090">mouse</span>
5' Genomic organisation of Fgf-10. A novel Fgf-10 transcription start site 653 nucleotides 5' to the Entrez published site was identified by RLM-RACE using total RNA isolated from embryonic day 18.5 mouse lung (A). Analysis of the potential promoter region of Fgf-10 (-500 to +1 bp) identified a string of 12 PEA3-binding sites approximately 360 to 240 bp upstream of the novel start site. The novel FGF-10 cDNA was confirmed by PCR analysis of cDNA and genomic (gDNA) samples (from E18.5 mouse lung) using forward primers specific to the genomic sequence immediately upstream of the predicted start site (grey) and at the predicted start of exon 1 (black), together with a common reverse primer (black) (B). PCR products of the expected size were obtained from both cDNA and gDNA samples when using the inner primer pair, confirming the predicted Fgf-10 start site was transcribed. The gDNA primer set yielded no product with the cDNA sample, as predicted, but amplified a clear band in the gDNA sample. Primers specific for cDNA (housekeeping gene hPRT, with primers spanning an intron to prevent amplification of gDNA) and gDNA (known intron sequence from Fgf-3) confirmed the integrity of both DNA samples and the lack of gDNA contamination.
###end p 121
###begin p 122
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 119 125 119 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 130 134 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pea3</italic>
###xml 150 156 150 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 161 167 161 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 201 205 201 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pea3</italic>
###xml 492 498 491 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 612 617 611 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 940 946 939 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 74 80 <span type="species:ncbi:10090">murine</span>
PEA3 binds to the Fgf-10 promoter region. RT-PCR showed that immortalised murine lung endothelial cells expressed both Fgf-10 and Pea3 (primers as in Fig. 1 for Fgf-10 and the cDNA and gDNA controls). Pea3 primers were designed flanking an intron such that they amplified only cDNA (A). Western blotting of 60 mug whole-cell lysate from the same cell line showed a clear band at 70 kDa, corresponding to PEA3 (B). ChIP analysis using the same anti-PEA3 antibody showed that PEA3 binds to the Fgf-10 promoter region (C). Immunoprecipitation with an antibody to RNA polymerase II followed by PCR using primers for GAPDH was used as a positive control for the ChIP assay (upper panel), with IgG and no antibody conditions used as negative controls. Presence and integrity of the ChIP input DNA was confirmed by PCR, using genomic DNA purified from ES cells as a positive control for primer efficiency. ChIP analysis using primers specific for Fgf-10 yielded a specific PCR product both with the anti-RNA polymerase II immunoprecipitate and, more strongly, with the anti-PEA3 immunoprecipitate.
###end p 122
###begin p 123
###xml 59 65 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pea3</italic>
###xml 341 345 341 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pea3</italic>
###xml 659 665 659 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 734 747 734 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;Ct</sup>
###xml 1008 1009 1000 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 236 241 <span type="species:ncbi:10090">mouse</span>
RNAi-mediated knockdown of PEA3 results in upregulation of Fgf-10 expression. Transfection with RNAi targeted to the PEA3-coding sequence resulted in a 64% drop in Pea3 expression levels, by 24 h and persisting at 48 h, in immortalised mouse lung endothelial cells (A). Cells transfected with a scrambled RNAi control pool showed a level of Pea3 expression identical to that seen in mock-transfected cells (data not shown). This decrease in PEA3 mRNA level was mirrored by a decrease of 34% in the level of PEA3 protein in cell lysates prepared 48 h post-transfection (B). By 48 h post-transfection, cells treated with PEA3 RNAi showed a 2.6-fold increase in Fgf-10 expression, as measured by real-time RT-PCR and analysed using the 2-DeltaDeltaCt method (C). All quantitation represents data from at least three independent experiments, and reflects either real-time RT-PCR data (n⩾3; each in triplicate) (A, C) or Western blot densitometry (n=3) (B). Statistical significance was determined with Student's t-test or Mann-Whitney Rank Sum test (PEA3 mRNA expression after 48 h). Results were considered significant at P<0.05 (*).
###end p 123
###begin p 124
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 461 467 461 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 779 792 779 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;Ct</sup>
###xml 1046 1047 1038 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 85 90 <span type="species:ncbi:9606">human</span>
Over-expression of PEA3 in MDA-MB-231 cells decreases Fgf-10 expression. Full-length human PEA3 cDNA (NM_001079675.1) was cloned into the pcDNA4/TO expression vector and transfected into the metastatic breast cancer cell line MDA-MB-231, with empty vector transfection serving as a control. PEA3 transfection resulted in a dramatic increase in both PEA3 mRNA (A) and protein (B) expression levels after 48 h. Concomitant with this, real-time RT-PCR showed that Fgf-10 expression was reduced to approximately 73% of the level measured in control cells (A), and this was reflected in a similar decrease (70%) in protein levels (B). HPRT and tubulin levels were measured as loading/quality controls for mRNA and protein, respectively. Real-time RT-PCR data were analysed using the 2-DeltaDeltaCt method. All quantitation represents data from at least three independent experiments, and reflects either real-time RT-PCR data (n=5; each in triplicate) (A) or Western blot densitometry (n=3) (B). Statistical significance was determined with Student's t-test. Results were considered significant at P<0.05 (*).
###end p 124
###begin p 125
###xml 152 153 152 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 292 295 292 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 866 867 864 865 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
Reduction of cell migration by over-expression of PEA3 in breast cancer cells is rescued by exogenous FGF-10 treatment. MDA-MB-231 and MCF-7 cells (1x105) transfected either with empty vector (white and light grey bars) or pcDNA4/TO-PEA3 (black and dark grey bars), were plated onto Transwell(R) filters in 24-well plates 36 h post-transfection. Cells were incubated overnight in medium without FBS supplemented with 0.1% BSA and with (grey bars) or without (black and white bars) recombinant FGF-10 (100 ng/ml), where the lower surface of the membrane had been coated with fibronectin (black bars). After 12 h, for both assay conditions, significantly fewer PEA3-transfected cells had migrated to the lower surface, when compared to controls (*p<0.05; **p<0.01; ***p<0.001; ANOVA followed by Newman-Keuls test) (A). PEA3- and/or empty vector-transfected cells (5x104) were plated in a 36-well plate 48 h post-transfection in serum-free medium with or without FGF-10 (100 ng/ml). Cells were trypsinised and counted 12 h after plating, revealing no significant difference between the various conditions in terms of cell proliferation (B).
###end p 125
###begin p 126
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pea3</italic>
###xml 344 350 344 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
###xml 479 485 479 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf-10</italic>
Model for PEA3-dependent regulation of FGF-10 in normal and malignant cells. In a non-malignant epithelial cell expressing FGFR1B or FGFR2B, FGF-10 secreted from a nearby cell can act in a paracrine fashion to activate its receptors and upregulate target genes, including Pea3. PEA3 protein can then bind to specific consensus sequences in the Fgf-10 promoter, blocking transcription. In the cancer cells we used, PEA3 protein was unstable, meaning that it could not bind to the Fgf-10 promoter. As a result, FGF-10 was expressed and able to stimulate its receptors in an autocrine fashion, thus providing the cancer cell with a strong growth-promoting signal.
###end p 126
###begin p 127
Oligonucleotides (adapters and primers) used in this study.
###end p 127
###begin p 128
Engineered BamHI and XbaI recognition sites, respectively, are given in bold.
###end p 128
###begin p 129
excluding genomic DNA
###end p 129
###begin p 130
where transcription starts
###end p 130
###begin p 131
Primers in the promoter region
###end p 131
###begin p 132
directly upstream of the predicted transcription start site
###end p 132
###begin p 133
genomic DNA control primers
###end p 133

